Interaction of sulphonylurea derivatives with vascular ATP-sensitive potassium channels in humans

Diabetologia

Volumn 39, Issue 9, 1996, Pages 1083-1090

  Bijlstra, P J ^a   Lutterman, J A ^a   Russel, F G M ^a   Thien, T ^a   Smits, P ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cardioprotection; Diazoxide; Forearm blood flow; Glibenclamide; Glomepiride; Potassium channels; Sulponylurea derivatives; Vascular

Indexed keywords

ADENOSINE TRIPHOSPHATE; DIAZOXIDE; GLIBENCLAMIDE; GLIMEPIRIDE; NITROPRUSSIDE SODIUM; PLACEBO; POTASSIUM CHANNEL; SULFONYLUREA DERIVATIVE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FOREARM BLOOD FLOW; HEART PROTECTION; HUMAN; HUMAN EXPERIMENT; INTRAARTERIAL DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PLETHYSMOGRAPHY; PRIORITY JOURNAL; VASCULARIZATION; VASODILATATION;

EID: 0029839401     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00400658     Document Type: Article

References (41)

1. Groop LC (1992) Sulfonylureas in NIDDM. Diabetes Care 15: 737-754
2. Gerich JE (1989) Oral hypoglycemic agents. N Engl J Med 321: 1231-1245
3. + channels in arterial smooth muscle. Science 245: 177-180
4. Edwards G, Weston AH (1990) Potassium channel openers and vascular smooth muscle relaxation. Pharmacol Ther 48: 237-258
5. Nichols CG, Ripoll C, Lederer WJ (1991) ATP-sensitive potassium channel modulation of the guinea pig ventricular action potential and contraction. Circ Res 68: 280-287
6. Brayden JE (1991) Hyperpolarization and relaxation of resistance arteries in response to adenosine diphosphate. Distribution and mechanism of action. Circ Res 69: 1415-1420
7. + channels protect the myocardium against ischaemia/reperfusion damage. Circ Res 69: 571-581
8. Ashford ML, Bond CT, Blair TA, Adelman JP (1994) Cloning and functional expression of a rat heart K ATP channel. Nature 370: 456-459
9. Niki I, Ashcroft SJ (1993) Characterization and solubilization of the sulphonylurea receptor in rat brain. Neuropharmacology 32: 951-957
10. Schwanstecher M, Brandt C, Behrends S, Schaupp U, Panten U (1992) Effect of MgATP on pinacidil-induced displacement of glibenclamide from the sulphonylurea receptor in a pancreatic beta-cell line and rat cerebral cortex. Br J Pharmacol 106: 295-301
11. Ogawa N, Fukata Y, Kaneta S, Jinno Y, Fukushima H, Nishikori K (1992) Comparison of KRN2391 with nicorandil and nifedipine on canine coronary blood flow: antagonism by glibenclamide. J Cardiovasc Pharmacol 20: 11-17
12. Aversano T, Ouyang P, Silverman H (1991) Blockade of the ATP-sensitive potassium channel modulates reactive hyperemia in the canine coronary circulation. Circ Res 69: 618-622
13. + channel blocker. Circulation 90: 700-705
14. Gross GJ, Auchampach JA (1992) Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 70: 223-233
15. + channel mediates hypotension in endotoxemia and hypoxic lactic acidosis in the dog. J Clin Invest 89: 2071-2074
16. Ballagi Pordany G, Nemeth M, Aranyi Z, et al (1992) Effect of glimepiride on the electrical activity of isolated rabbit heart muscle. Arzneim Forsch 42: 111-113
17. Whitney RJ (1953) The measurement of volume changes in human limbs. J Physiol (Camb) 121: 1-27
18. Elia M, Kurpad A (1993) What is the blood flow to resting human muscle? Clin Sci 84: 559-563
19. Lenders JW, Janssen GJ, Smits P, Thien Th (1991) Role of the wrist cuff in forearm plethysmography. Clin Sci 80: 413-417
20. Coppack SW, Lant AF, McIntosh CS, Rodgers AV (1990) Pharmacokinetic and pharmacodynamic studies of glibenclamide in non-insulin-dependent diabetes mellitus. Br J Clin Pharmacol 29: 673-684
21. Rupp v W, Christ O, Heptner W (1969) Resorption, Ausscheidung und Metabolismus nach intravenoser und oraler Gabe von HB 419- 14C an Menschen. Arzneim Forsch 19: 1428-1434
22. Niki I, Nicks JL, Ashcroft SJ (1990) The beta-cell glibenclamide receptor is an ADP-binding protein. Biochem J 268: 713-718
23. Geisen K (1988) Special pharmacology of the new sulphonylurea glimepiride. Arzneim Forsch 38 (II):1120-1130
24. Ratheiser K, Korn A, Waldhausl W, et al (1993) Dose relationship of stimulated insulin production following intravenous application of glimepiride in healthy man. Arzneim Forsch 43: 856-858
25. Muller G, Hartz D, Punter J, Okonomopulos R, Kramer W (1994) Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. I. Binding characteristics. Biochim Biophys Acta 1191: 267-277
26. Kramer W, Muller G, Girbig F, et al (1994) Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. II. Photoaffinity labeling of a 65 kDa protein byglimepiride. Biochim Biophys Acta 1191: 278-290
27. Draeger E (1995) Clinical profile of glimepiride. Diabetes Res Clin Pract 28 [Suppl]:S139-S146
28. Uihlein M, Sistovaris N (1982) High-performance liquid column and thin-layer chromatographic determination of human serum glibenclamide at therapeutic levels. J Chromatogr 227: 93-101
29. Lehr KH, Damm P (1990) Simultaneous determination of the sulphonylurea glimepiride and its metabolites in human serum and urine by high-performance liquid chromatography after pre-column derivatization. J Chromatogr 526: 497-505
30. Greenfield ADM, Patterson GC (1954) Reactions of the blood vessels of the human forearm to increases in transmural pressure. J Physiol (Camb) 125: 508-524
31. + channel openers. J Vasc Res 30: 2-12
32. Quast U (1992) Potassium channel openers: pharmacological and clinical aspects. Fundam Clin Pharmacol 6: 279-293
33. Hajdu P, Kohler KF, Schmidt FH, Springier H (1969) Physikalisch-chemische und analytische Untersuchungen an HB 419. Drug Res 19: 1381-1386
34. Ashcroft SJ, Ashcroft FM (1990) Properties and functions of ATP-sensitive K-channels. Cell Signal 2: 197-214
35. Ozanne SE, Guest PC, Hutton JC, Hales CN (1995) Intracellular localization and molecular heterogeneity of the sulphonylurea receptor in insulin-secreting cells. Diabetologia 38: 277-282
36. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL (1991) Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 87: 2246-2252
37. + channel openers in rat aorta. J Biol Chem 267: 11689-11692
38. Schwanstecher M, Schwanstecher C, Dickel C, Chudziak F, Moshiri A, Panten U (1994) Location of the sulphonylurea receptor at the cytoplasmic face of the beta-cell membrane. Br J Pharmacol 113: 903-911
39. Marchetti P, Giannarelli R, di Carlo A, Navalesi R (1991) Pharmacokinetic optimisation of oral hypoglycaemic therapy. Clin Pharmacokin 21: 308-317
40. Billman GE, Avendano CE, Halliwill JR, Burroughs JM (1993) The effects of the ATP-dependent potassium channel antagonist, glyburide, on coronary blood flow and susceptibility to ventricular fibrillation in unanesthesised dogs. J Cardiovasc Pharmacol 21: 197-204
41. Sanguinetti MC (1992) Modulation of potassium channels by antiarrhythmic and antihypertensive drugs. Hypertension 19: 228-236